Literature DB >> 10636852

Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter.

N Chen1, J V Ferrer, J A Javitch, J B Justice.   

Abstract

The effect of covalent sulfhydryl modification on dopamine uptake by the human dopamine transporter was determined by rotating disc electrode voltammetry. A transporter construct, X5C, with five mutated cysteines (C90A, C135A, C306A, C319F, and C342A) and the constructs into which the wild-type cysteines were substituted back into X5C, one at a time, all showed nearly normal binding affinity for [(3)H]CFT and for cocaine, but they displayed significant reductions in K(m) and V(max) for DA uptake. Reaction of Cys-90 or Cys-306 with impermeant methanethiosulfonate derivatives enhanced dopamine uptake to a similar extent as the previously observed enhancement of [(3)H]CFT binding caused by the same reaction, suggesting that cocaine may bind preferentially to a conformation in the transport cycle. m-Tyramine increased the rate of reaction of (2-aminoethyl)methanethiosulfonate (MTSEA) with X-A342C, the construct with a cytoplasmic loop residue Cys-342 restored. This m-tyramine-induced increase in reactivity appeared to require the inward transport rather than the outward transport or external binding of m-tyramine, and it was prevented by cocaine. Thus, inward translocation of substrates may involve structural rearrangement of hDAT, which likely exposes Cys-342 to reaction with MTSEA, and Cys-342 may be located on a part of the transporter associated with cytoplasmic gating.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636852     DOI: 10.1074/jbc.275.3.1608

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Exploration of novel motifs derived from mouse cDNA sequences.

Authors:  Hideya Kawaji; Christian Schönbach; Yo Matsuo; Jun Kawai; Yasushi Okazaki; Yoshihide Hayashizaki; Hideo Matsuda
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

2.  Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.

Authors:  Erik R Hill; Xiaoqin Huang; Chang-Guo Zhan; F Ivy Carroll; Howard H Gu
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

3.  Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.

Authors:  Claus Juul Loland; Lene Norregaard; Thomas Litman; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 4.  Model systems for analysis of dopamine transporter function and regulation.

Authors:  Moriah J Hovde; Garret H Larson; Roxanne A Vaughan; James D Foster
Journal:  Neurochem Int       Date:  2018-09-01       Impact factor: 3.921

5.  Functional role of the intracellular loop linking transmembrane domains 6 and 7 of the human dipeptide transporter hPEPT1.

Authors:  Liya Xu; Yiyu Li; Ian S Haworth; Daryl L Davies
Journal:  J Membr Biol       Date:  2010-11-21       Impact factor: 1.843

6.  Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.

Authors:  Samuel U Park; Jasmine V Ferrer; Jonathan A Javitch; Donald M Kuhn
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Authors:  Yvette Dehnes; Jufang Shan; Thijs Beuming; Lei Shi; Harel Weinstein; Jonathan A Javitch
Journal:  Neurochem Int       Date:  2014-02-24       Impact factor: 3.921

8.  Molecular model of the neural dopamine transporter.

Authors:  Aina Westrheim Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

9.  Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge.

Authors:  Jon D Gaffaney; Madhur Shetty; Bruce Felts; Akula-Bala Pramod; James D Foster; L Keith Henry; Roxanne A Vaughan
Journal:  Neurochem Int       Date:  2013-11-20       Impact factor: 3.921

10.  Cocaine analogue conjugated magnetic nanoparticles for labeling and imaging dopaminergic neurons.

Authors:  Mike Jeon; Guanyou Lin; Zachary R Stephen; Josey E Vechey; Manjot Singh; Richard Revia; Amy Hauck Newman; Diana Martinez; Miqin Zhang
Journal:  Biomater Sci       Date:  2020-06-09       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.